stockrowAtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.
- Revenue
- +15.0%
- EPS
- +1,583.9%
- Free cash flow
- −0.73%
- Total debt
- −17.3%
Quarter to September 2026, against a year earlier
Follow ATRC
Alert me
AtriCure, Inc. (ATRC) Return on assets
AtriCure, Inc.'s return on assets over the twelve months to 30 September 2026 was 2.20%, up 4.0 percentage points from fiscal 2025 (−1.81%). Over the past ten years it has ranged from −12.6% (fiscal 2015) to 7.55% (fiscal 2021); the current reading is higher than 91% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | −1.81% | 5.50 |
| FY2024 | −7.31% | (2.23) |
| FY2023 | −5.08% | 2.66 |
| FY2022 | −7.74% | (15.29) |
| FY2021 | 7.55% | 15.12 |
| FY2020 | −7.57% | 0.13 |
| FY2019 | −7.70% | (0.93) |
| FY2018 | −6.77% | 3.11 |
| FY2017 | −9.88% | 2.25 |
| FY2016 | −12.1% | 0.48 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| NVST Envista Holdings Corporation compare | 11.3% |
| MMSI Merit Medical Systems, Inc. compare | 5.76% |
| STVN Stevanato Group S.p.A. compare | 5.50% |
| ATRC AtriCure, Inc. | 2.20% |
| ICUI ICU Medical, Inc. compare | 1.50% |
| WRBY Warby Parker Inc. compare | 1.00% |
| XRAY DENTSPLY SIRONA Inc. compare | −2.23% |
| MMED MiniMed Group, Inc. compare | −6.27% |
| PLSE Pulse Biosciences, Inc compare | −54.0% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on ATRC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement